Neurofibromatosis type 1 and cardiac manifestations

Turk Kardiyol Dern Ars. 2015 Dec;43(8):714-6. doi: 10.5543/tkda.2015.27557.

Abstract

Objective: Cardiac manifestations of neurofibromatosis type 1 (NF1) may include hypertension, congenital heart disease, and hypertrophic cardiomyopathy. The aim of this study was to evaluate cardiac abnormalities in patients with NF1.

Methods: Sixty-five NF1 patients (mean age: 9±4.48 years) were retrospectively studied. Standard electrocardiography and echocardiography were performed in all patients.

Results: Cardiac abnormalities were found in 11 of the 65 patients (15.3%). Five patients had mitral valve regurgitation, 2 patients had secundum atrial septal defect, 1 patient had pulmonary valvular stenosis, 1 patient had ventricular septal defect, 1 patient had tricuspid valve regurgitation, and 1 patient had aortic valve regurgitation.

Conclusion: Cardiac abnormalities have potential long-term hemodynamic consequences that justify an early diagnosis. Thus, for any patient with NF1, a cardiologic assessment is mandatory at the time of diagnosis and with regular follow-up intervals.

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Heart Diseases / complications*
  • Heart Diseases / epidemiology*
  • Humans
  • Male
  • Neurofibromatosis 1 / complications*
  • Neurofibromatosis 1 / epidemiology*
  • Retrospective Studies